These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23062857)

  • 1. Economic aspects of the association between diabetes and depression: a systematic review.
    Molosankwe I; Patel A; José Gagliardino J; Knapp M; McDaid D
    J Affect Disord; 2012 Oct; 142 Suppl():S42-55. PubMed ID: 23062857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the cost effectiveness of interventions to promote the physical health of people with mental health problems: a systematic review.
    Park AL; McDaid D; Weiser P; Von Gottberg C; Becker T; Kilian R;
    BMC Public Health; 2013 Aug; 13():787. PubMed ID: 23988266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of integrated care for elderly depressed patients in the PRISM-E study.
    Wiley-Exley E; Domino ME; Maxwell J; Levkoff SE
    J Ment Health Policy Econ; 2009 Dec; 12(4):205-13. PubMed ID: 20195008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the impact of enhanced depression treatment on workplace functioning and costs: a cost-benefit approach.
    Lo Sasso AT; Rost K; Beck A
    Med Care; 2006 Apr; 44(4):352-8. PubMed ID: 16565636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economics of psychosocial factors in patients with cardiovascular disease.
    Rodwin BA; Spruill TM; Ladapo JA
    Prog Cardiovasc Dis; 2013; 55(6):563-73. PubMed ID: 23621966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation.
    Kearns B; Rafia R; Leaviss J; Preston L; Brazier JE; Palmer S; Ara R
    BMC Health Serv Res; 2017 Jan; 17(1):78. PubMed ID: 28118838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder.
    Bereza BG; Machado M; Einarson TR
    Clin Ther; 2009 Jun; 31(6):1279-308. PubMed ID: 19695395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus.
    Simon GE; Katon WJ; Lin EH; Rutter C; Manning WG; Von Korff M; Ciechanowski P; Ludman EJ; Young BA
    Arch Gen Psychiatry; 2007 Jan; 64(1):65-72. PubMed ID: 17199056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluations of adult weight management interventions: a systematic literature review focusing on methods used for determining health impacts.
    Griffiths UK; Anigbogu B; Nanchahal K
    Appl Health Econ Health Policy; 2012 May; 10(3):145-62. PubMed ID: 22439628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing the societal burden of depression: a review of economic costs, quality of care and effects of treatment.
    Donohue JM; Pincus HA
    Pharmacoeconomics; 2007; 25(1):7-24. PubMed ID: 17192115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluations of smoking cessation and relapse prevention programs for pregnant women: a systematic review.
    Ruger JP; Emmons KM
    Value Health; 2008; 11(2):180-90. PubMed ID: 17854435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
    Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
    BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of diagnosed depression on healthcare costs in adults with and without diabetes: United States, 2004-2011.
    Egede LE; Bishu KG; Walker RJ; Dismuke CE
    J Affect Disord; 2016 May; 195():119-26. PubMed ID: 26890289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the economic impact of screening and treatment for depression in the workplace.
    Evans-Lacko S; Koeser L; Knapp M; Longhitano C; Zohar J; Kuhn K
    Eur Neuropsychopharmacol; 2016 Jun; 26(6):1004-13. PubMed ID: 27085517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does shared care help in the treatment of depression?
    Agius M; Murphy CL; Zaman R
    Psychiatr Danub; 2010 Nov; 22 Suppl 1():S18-22. PubMed ID: 21057395
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.